Key facts
- It has raised $60.0M; the latest was Early Stage VC in Nov 2025.
- Notable investors include K5 Global, Balaji Srinivasan, Naval Ravikant, Pari Passu Venture Partners, North Island Ventures — 12 tracked in total.
- Status: Privately Held (backing).
- ·The complete investor list — 12 names
- ·Watchlist + deal alerts for Blueprint
- ·The full record, as it builds
Funding rounds
No funding rounds for Blueprint are on record yet — either the company hasn't raised institutional capital, or the raise hasn't surfaced in our sources.
About Blueprint
Producer of nutritional supplements intended to enhance longevity and overall wellness through clinically tested formulations. The company's products combine essential nutrients, antioxidants, and functional ingredients verified through transparent research and population-level studies, enabling consumers to improve energy, recovery, and long-term health through scientifically backed daily nutrition.
- Sector
- Consumer Products and Services (B2C)
- HQ
- Los Angeles, CA, United States
- Founded
- 2021
- Employees
- 38
- Website
- blueprint.bryanjohnson.com/
- Ownership
- Privately Held (backing)
Blueprint doesn't have a composite mark yet — a PA Mark is published once enough pricing inputs exist (trade prints, fund marks, round prices). The rest of the record below builds toward it.
Recorded secondary trades
No secondary trades in Blueprint shares have been recorded yet. When a print lands — third-party, direct report, or platform — it appears here with structure, source, and price.
Institutional fund marks
No SEC-registered fund has reported a fair-value mark on Blueprint in its N-PORT filings yet. We sweep new filings monthly.